Home » Topics » BioWorld Science

BioWorld Science
RSS

Burnet Institute and Moderna partner on novel mRNA vaccines for infectious diseases

May 18, 2022

RO-634, bispecific protein for the treatment of back of the eye disease

May 18, 2022

rVCG-Pmp18.3, a novel Chlamydia abortus vaccine with promising efficacy in mice

May 18, 2022

Sanofi describes enzyme replacement gene therapy for metachromatic leukodystrophy

May 18, 2022

Model Medicines granted request for pre-IND meeting with FDA for antiviral MDL-001

May 18, 2022

Mission Therapeutics patents USP30 inhibitors

May 18, 2022

Patient-derived antibody activates innate immune system

May 18, 2022

Evotec International discovers integrated stress response pathway modulators

May 18, 2022

University of Ljubljana presents dual TLR7/NOD2 agonists

May 18, 2022

Palacky University describes neuroprotective cholestane derivatives

May 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...